- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Jul 14, 2026
B-06970150908997uE3 CLIA Microparticles is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — General. Manufactured by Autobio Diagnostics Co., Ltd.. Placed on the EU market in France. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
06970150908997CMN0402(01)06970150908997
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0102050203UNCONJUGATED (FREE) ESTRIOL1 warning recorded — scroll inside the panel to see all entries.
OTHER
CN-MF-000003348Primary placement in France; available across 1 country total.
| Country | On market since | Until |
|---|---|---|
| FrancePrimary placement | — | Still on market |
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →No certificate specifically references this device's Basic UDI-DI.
Certificate health across this manufacturer's portfolio.
V10 071134 0020SupplementedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →697015090000079HPOn the marketTumour Marker Control II697015090000079HPOn the marketuE3 CLIA MicroparticalsB-06942359505871On the marketVCA IgA CLIA MicroparticlesB-06975577176349On the marketVCA IgA CLIA MicroparticlesB-06975577176318On the marketVCA IgG CLIA MicroparticlesB-06975577176554On the market